ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4647
0.23%
Brent Oil
82.275
0.37%
Bitcoin
66,139.22
-0.93%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. HilleVax Inc (HLVX)

  7. HilleVax Inc (HLVX) Noticias

HLVX

HilleVax (HLVX)

HilleVax Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HLVX
FechaHoraFuenteTítuloSímboloCompañía
10/06/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
09/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HLVXHilleVax Inc
09/05/202415:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
09/05/202415:05GlobeNewswire Inc.HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
20/03/202415:00GlobeNewswire Inc.HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
12/02/202418:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
05/02/202415:05GlobeNewswire Inc.HilleVax to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:HLVXHilleVax Inc
26/01/202416:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
18/01/202406:49Dow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
18/01/202406:00GlobeNewswire Inc.HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
08/01/202406:00GlobeNewswire Inc.HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of ChinaNASDAQ:HLVXHilleVax Inc
03/01/202417:28GlobeNewswire Inc.HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
18/12/202316:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
09/11/202315:05GlobeNewswire Inc.HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
01/11/202315:48GlobeNewswire Inc.HilleVax to Present at Upcoming Investor ConferencesNASDAQ:HLVXHilleVax Inc
26/09/202315:01GlobeNewswire Inc.HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
25/09/202306:00GlobeNewswire Inc.HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:HLVXHilleVax Inc
20/09/202315:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HLVXHilleVax Inc
19/09/202319:05GlobeNewswire Inc.HilleVax Announces Pricing of Public Offering of Common StockNASDAQ:HLVXHilleVax Inc
19/09/202315:09GlobeNewswire Inc.HilleVax Announces Proposed Public Offering of Common StockNASDAQ:HLVXHilleVax Inc
14/08/202306:00GlobeNewswire Inc.HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
22/06/202315:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HLVXHilleVax Inc
20/06/202317:07Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:HLVXHilleVax Inc
09/06/202317:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HLVXHilleVax Inc
12/05/202315:56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HLVXHilleVax Inc
12/05/202315:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HLVXHilleVax Inc
12/05/202315:05GlobeNewswire Inc.HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
10/05/202315:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:HLVXHilleVax Inc
09/05/202306:00GlobeNewswire Inc.HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of DirectorsNASDAQ:HLVXHilleVax Inc
28/04/202315:46Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HLVXHilleVax Inc
 Showing the most relevant articles for your search:NASDAQ:HLVX

Su Consulta Reciente

NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
FX
USDMXN
US Dollar vs MXN
USOTC
RHHBY
Roche (QX)
CCOM
US500
US 500
FX
EURUSD
Euro vs US Dollar
NYSE
NKE
Nike
NYSE
KO
Coca Cola
USOTC
BASFY
BASF (QX)
NASDAQ
TSLA
Tesla
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados